bioRxiv · 10.1101/339143
Trio deep-sequencing does not reveal unexpected mutations in Cas9-edited monkeys
Abstract
CRISPR-Cas9 is a widely-used genome editing tool, but its off-target effect remains a concern, especially in view of future clinical applications. Non-human primates (NHPs) share close genetic and physiological similarities with humans, making them an ideal preclinical model for developing Cas9-based therapies. However, no comprehensive in vivo off-target assessment has been conducted in NHPs. Here we performed whole genome trio sequencing of Cas9-treated monkeys. We found they only carried a small number of de novo mutations that can be explained by expected spontaneous mutations, and no unexpected mutations were detected.
Explore related subjects
Keep this discovery
Luo, X., He, Y., Zhang, C., He, X., Yan, L., Li, M., Hu, T., Hu, Y., Jiang, J., Meng, X., Ji, W., Zhao, X., Zheng, P., Xu, S., Su, B.. 2018-06-05. Trio deep-sequencing does not reveal unexpected mutations in Cas9-edited monkeys. https://doi.org/10.1101/339143
Cite the original work for its findings. Save a collection to share your selection of sources.